SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-026308
Filing Date
2023-09-19
Accepted
2023-09-19 16:10:16
Documents
13
Period of Report
2023-09-15
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arav20230918_8k.htm   iXBRL 8-K 34079
  Complete submission text file 0001437749-23-026308.txt   169837

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA arav-20230915.xsd EX-101.SCH 3409
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20230915_def.xml EX-101.DEF 11807
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20230915_lab.xml EX-101.LAB 15858
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20230915_pre.xml EX-101.PRE 12022
7 EXTRACTED XBRL INSTANCE DOCUMENT arav20230918_8k_htm.xml XML 2653
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36361 | Film No.: 231263815
SIC: 2834 Pharmaceutical Preparations